세포배양 단백질 표면 코팅 시장 보고서 : 단백질 유래, 코팅 유형, 용도, 지역별(2024-2032년)

The global cell culture protein surface coating market size reached US$ 730.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,170.8 Million by 2032, exhibiting a growth rate (CAGR) of 12.5% during 2024-2032.

A cell culture protein surface coating helps in enhancing the adhesion and proliferation of different cells, such as leukocytes, neurons, epithelial and fibroblasts, in vitro isolation and cultivation process. The inner surface of a flask or petri dish is generally coated with extracellular matrix or proteins like laminin, collagen, fibronectin and vitronectin. Cell culture enables researchers to grow animal or plant cells in a favorable artificial environment, which further assists in understanding the roles of proteins in cell attachment, migration and function. It also aids in developing model systems for research, studying cellular functions, stem cell research, drug discovery and genetic engineering.

Owing to the growing prevalence of chronic diseases, the interest of scientists and various biotechnology companies in cancer and stem cell research is escalating around the world. Stem cells are effective in treating cancer, brain diseases, cell deficiency therapy, and cardiovascular diseases. This represents one of the significant factors, which is strengthening the global cell culture protein surface coating market growth. Apart from this, the adoption of 3D cell cultures has increased in recent years, which has also contributed to market growth. A 3D cell culture refers to a process that assists in growing biological cells in a controlled environment, wherein these cells can interact with their surroundings. Furthermore, inflating income levels and increasing healthcare expenditures are projected to strengthen the market growth in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cell culture protein surface coating market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on protein source, type of coating and application.

Breakup by Protein Source:

Animal-derived Protein

Human-derived Protein

Synthetic Protein

Plant-derived Protein

Breakup by Type of Coating:

Self-Coatings

Pre-Coatings

Microwell Plates

Petri Dish

Flask

Slides

Others

Breakup by Application:

Scientific Research

Industrial Production

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abcam plc, Agilent Technologies, BioVision Inc., Corning Incorporated, Greiner Bio-One International GmbH, Kollodis BioSciences Inc., Merck KGaA, PerkinElmer Inc., Promega Corporation, Qiagen N.V., Sartorius AG, Thermo Fisher Scientific Inc., Trevigen Inc. (Bio-Techne), Viogene, etc.

Key Questions Answered in This Report:

• How has the global cell culture protein surface coating market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the global cell culture protein surface coating market?
• What is the breakup of the market based on the protein source?
• What is the breakup of the market based on the type of coating?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global cell culture protein surface coating market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cell Culture Protein Surface Coating Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Protein Source

• 6.1 Animal-derived Protein
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Human-derived Protein
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Synthetic Protein
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Plant-derived Protein
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Type of Coating

• 7.1 Self-Coatings
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Pre-Coatings
  • 7.2.1 Market Trends
  • 7.2.2 Major Types
    • 7.2.2.1 Microwell Plates
    • 7.2.2.2 Petri Dish
    • 7.2.2.3 Flask
    • 7.2.2.4 Slides
    • 7.2.2.5 Others
  • 7.2.3 Market Forecast

8 Market Breakup by Application

• 8.1 Scientific Research
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Industrial Production
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abcam plc
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Agilent Technologies
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 BioVision Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Corning Incorporated
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Greiner Bio-One International GmbH
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Kollodis BioSciences Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Merck KGaA
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 PerkinElmer Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Promega Corporation
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Qiagen N.V.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Sartorius AG
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Thermo Fisher Scientific Inc.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis
  • 14.3.13 Trevigen Inc. (Bio-Techne)
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
  • 14.3.14 Viogene
    • 14.3.14.1 Company Overview
    • 14.3.14.2 Product Portfolio